Laboratoires Servier
Tracked across 2 events · 15 articles · First seen Feb 05, 2026 · Last active Mar 06, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Laboratoires Servier is acquiring Day One Biopharmaceuticals, Inc. for approximately $2.5 billion, reinforcing its position in oncology targeted therapies and expanding its pipeline in rare cancers, particularly pediatric low-grade glioma. This acquisition aligns with Laboratoires Servier's 2030 ambition to develop innovative treatments for patients with high unmet medical needs.
Mar 06, 2026 · 8 articles
Tech
Laboratoires Servier's General Manager BELUX, Ziad Matta, participated in the summit, contributing to discussions on AI's application in healthcare. This indicates Laboratoires Servier's interest in leveraging AI for patient care.
Feb 05, 2026 · 7 articles
Baker McKenzie
legal counsel
↔
Laboratoires Servier
Baker McKenzie is serving as legal counsel to Laboratoires Servier.
Olivier Laureau
President
↔
Laboratoires Servier
Olivier Laureau is the President of Laboratoires Servier.
NEWSDESK
Track Laboratoires Servier live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard